CTOs on the Move

Nevakar

www.nevakar.com

 
Nevakar is a specialty pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.nevakar.com
  • 1019 US Highway 202-206 Building K
    Bridgewater, NJ USA 08807
  • Phone: 908.367.7400

Executives

Name Title Contact Details

Funding

Nevakar raised $55M on 07/28/2016
Nevakar raised $30M on 11/30/2018

Similar Companies

WCG Clinical Services

WCG is the world`s largest and most trusted provider of regulatory and ethical review services for human research. The pioneer of independent ethical review, WCG continues to drive ingenuity in the clinical research space. Today, WCG`s solutions are built upon the foundation of ethical review, but have grown to include a suite of complementary services and technologies that expand the capabilities of the modern research professional. WCG delivers transformational solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. WCG is proud to serve the individuals on the frontlines of science and medicine, and the organizations that strive to develop new products and therapies to improve the quality of human health. It is our role to empower them to accelerate advancement, while ensuring that the risks of progress never outweigh the value of human life.

Inkblot Therapy

Inkblottherapy.com offers affordable, secure video counselling any time, any place. We are on a mission to increase accessibility to high quality mental health counselling in Canada.

Asembia

Asembia constantly connects and strengthens the pharmaceutical industry to improve the experiences of patients everywhere.

Highland Therapeutics

Highland Therapeutics Inc., a Toronto-based specialty pharmaceutical company. It is a specialty pharmaceutical company leveraging its proprietary technologies to optimize the delivery of previously approved drug products.

Arrakis Therapeutics

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts.